19 June 2013
Keywords: fda, bans, sale, centeon, products, food, drug
Article | 03 February 1997
- The US Food and Drug Administration has barred Rhone-PoulencRorer/Hoechst's US joint-venture Centeon from selling most of its drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com